Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.

20 May 2011

HealthGrades identifies major flaws in hospital ratings study

The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.

20 May 2011

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen Corporation announced today that it has received approval from the Food and Drug Administration to initiate a Phase 1 clinical trial of RG3039, a potential treatment for Spinal Muscular Atrophy.

19 May 2011

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.

19 May 2011

Thirty endoscopy units earn ASGE recognition for safety and quality

The American Society for Gastrointestinal Endoscopy has recognized 30 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States.

19 May 2011

Takeda reaches agreement to acquire Nycomed

Takeda Pharmaceutical Company Limited and Nycomed A/S jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis.

19 May 2011

Two genes linked to worst cases of esophageal cancer

University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes.

19 May 2011

Synergy expands GC-C agonist technology to lower cholesterol

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.

18 May 2011

U-M C.S. Mott Children's Hospital ranks top in best pediatric specialty rankings

The University of Michigan's C.S. Mott Children's Hospital has earned the highest rankings in the state of Michigan and is among the best in the country in pediatric specialties according to the U.S. News Media Group's Best Children's Hospital rankings.

18 May 2011

Gut bacteria influences brain chemistry and behaviour: Research

For the first time, researchers at McMaster University have conclusive evidence that bacteria residing in the gut influence brain chemistry and behaviour.

18 May 2011

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.

17 May 2011

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, announced today that it has entered into an agreement with Sanofi to grant Sanofi a license for the development and commercialization of GBR 500, a novel monoclonal antibody for the treatment of Crohn's Disease and other inflammatory conditions.

17 May 2011

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.

16 May 2011

Salmonella enterica bacterium activates virulence genes through Fur protein

Salmonella enterica, one of the main causes of gastrointestinal infections, modulates its virulence gene expression, adapting it to each stage of the infection process, depending on the free iron concentration found in the intestinal epithelium of its host.

12 May 2011

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people.

12 May 2011

China Pharma first quarter revenue increases 20% to $18.1 million

China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the quarter ended March 31, 2011.

11 May 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced that GATTEX, a novel, recombinant analog of human glucagon-like peptide 2, was found to effectively and safely reduce parenteral support volume in adult short bowel syndrome-intestinal failure patients.

11 May 2011

Majority of urban NYC women with hepatitis B do not receive education, subsequent care

According to new research at Columbia Presbyterian Medical Center, high rates of chronic hepatitis B infection are found in pregnant minority and immigrant women in the New York City area, and most of them do not receive education, appropriate follow-up testing or referral, which is considered the standard of care for all persons newly identified as HBV carriers.

11 May 2011

New Crohn’s disease therapy on its way

In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.

11 May 2011

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

The Laboratory Department for Probiotics Research at the Juntendo University Graduate School of Medicine studied supplementation of probiotic fermented milk containing Lactobacillus casei strain Shirota in elderly individuals living at a nursing home and confirmed reduced fever associated with acute norovirus gastroenteritis.

10 May 2011

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

HealthGrades identifies major flaws in hospital ratings study

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

Thirty endoscopy units earn ASGE recognition for safety and quality

Takeda reaches agreement to acquire Nycomed

Two genes linked to worst cases of esophageal cancer

Synergy expands GC-C agonist technology to lower cholesterol

U-M C.S. Mott Children's Hospital ranks top in best pediatric specialty rankings

Gut bacteria influences brain chemistry and behaviour: Research

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Salmonella enterica bacterium activates virulence genes through Fur protein

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

China Pharma first quarter revenue increases 20% to $18.1 million

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

Majority of urban NYC women with hepatitis B do not receive education, subsequent care

New Crohn’s disease therapy on its way

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

Microbiology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Microbiology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in